Efficacy of Panobinostat for the Treatment of Multiple Myeloma

by Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Efstathios Kastritis, Maria Gavriatopoulou, Evangelos Terpos, Meletios Athanasios Dimopoulos
Published 2020-01-01

Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome

by Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Despina Fotiou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Maria Roussou, Ioanna Dialoupi, Panagiotis Malandrakis, Foteini Theodorakakou, Efstathios Kastritis, Evangelos Terpos, Meletios-Athanasios Dimopoulos
Published 2020-06-01

Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study

by Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Eirini Katodritou, Marie-Christine Kyrtsonis, Vassiliki Douka, Emmanouil Spanoudakis, Athanasios Papatheodorou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Maria Gavriatopoulou, Polyzois Makras, Efstathios Kastritis, Meletios A Dimopoulos
Published 2021-03-01

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Indu...

by Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Gerasimos-Petros Papassotiriou, Efstathios Kastritis, Alexandra Margeli, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Despina Fotiou, Maria Roussou, Maria Gavriatopoulou, Panagiotis Malandrakis, Erasmia Psimenou, Ioannis Papassotiriou, Meletios A. Dimopoulos
Published 2020-10-01

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment

by Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Despina Fotiou, Eleni-Dimitra Papanagnou, Magdalini Migkou, Foteini Theodorakakou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Ioannis P. Trougakos, Efstathios Kastritis, Meletios A. Dimopoulos
Published 2021-08-01

Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma

by Konstantinos Papadimitriou, Nikolaos Tsakirakis, Panagiotis Malandrakis, Panagiotis Vitsos, Andreas Metousis, Nikolaos Orologas-Stavrou, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Pothos, Despina Fotiou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios-Athanasios Dimopoulos, Evangelos Terpos, Ourania E. Tsitsilonis, Ioannis V. Kostopoulos
Published 2020-11-01

Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy

by Evangelos Terpos, Ioannis V. Kostopoulos, Efstathios Kastritis, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Pantelis Rousakis, Alexandra T. Argyriou, Nikolaos Kanellias, Despina Fotiou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Dimitrios C. Ziogas, Aristea-Maria Papanota, Marilyn Spyropoulou-Vlachou, Ioannis P. Trougakos, Ourania E. Tsitsilonis, Bruno Paiva, Meletios A. Dimopoulos
Published 2019-12-01

Aberrant Plasma Cell Contamination of Peripheral Blood Stem Cell Autografts, Assessed by Next-Generation Flow Cytometry, Is a Negative Predictor for Deep Response Post Autologous T...

by Ioannis V. Kostopoulos, Evangelos Eleutherakis-Papaiakovou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Nikolaos Orologas-Stavrou, Nikolaos Kanellias, Panagiotis Malandrakis, Christine-Ivy Liacos, Nikos E. Papaioannou, Aristea-Maria Papanota, Magdalini Migkou, Despina Fotiou, Maria Gavriatopoulou, Nikolaos V. Angelis, Efstathios Kastritis, Meletios-Athanasios Dimopoulos, Ourania E. Tsitsilonis, Evangelos Terpos
Published 2021-08-01